nektar.com - NKTR Net Assets per Single Share

Graphic logo of Nektar Therapeutics (NKTR)

Nektar Therapeutics (NKTR) develops innovative agents to strengthen immunity. The market capitalization trend, which currently stands at 26.30, reflects the impact of fierce competition within the oncology sector and the threat of acquisition by industry behemoths. Efficient biopharmaceutical logistics and strategic plant distribution ensure profit stability. The company is currently independently rebuilding its development pipeline following the collapse of a major alliance, effectively ruling out the possibility of mergers.

Nektar Therapeutics Inc (NKTR): Share Book Value from 07/04/2022 to 10/28/2026

nektar.com - analytical breakdowns and key metrics (NKTR)

- price and consensus price forecast:
Stock Quotes Nektar|NKTR - Analyst Forecast Prices
- market capitalization data:
Market Value Nektar Therapeutics Inc.|NKTR - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Nektar Therapeutics|NKTR - Net Asset Value|Market Capitalization to Book Value Ratio nektar.com|NKTR - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Nektar Therapeutics|NKTR - Long-Term Debt to Capital|Short-Term Debt to Equity Nektar Therapeutics Inc.|NKTR - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Nektar Therapeutics Inc.|NKTR - Company Long-Term Liabilities|Company Short-Term Debts Nektar Therapeutics
Fundamental company valuation:Nektar - NKTR
Manufactured products of Nektar Therapeutics Inc.

Nektar Therapeutics (NKTR) specializes in developing innovative immuno-oncology drugs utilizing unique patents. This indicator reflects the net asset value per common share. By analyzing the book value of equity per share, an investor assesses the actual asset backing of the business. This metric allows for the separation of the technological value of intellectual property from market speculation, which is critical for determining the fundamental stability of the biotechnology issuer.

Competitors of Nektar Therapeutics (NKTR)

Accounting Value per Share Argenx ARGX|BNTX: Book Price of a Share|Net Assets per Single Share Abivax Corp ABVX|ADMA (admabiologics.com) - Accounting Value of a Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Astria Therapeutics Inc - Net Asset Value per Share|enGene Bio (ENGN) - Net Assets per Single Share|RAPT - Equity per Share|Book Value per Share JBIO|ACRS (aclaristx.com) - Net Asset Value per Share|KYTX (Kyverna Therapeutics, Inc.) - Net Assets per Single Share|Book Value per Share Tiziana Life Sciences Ltd. (TLSA)|Accounting Value per Share Cabaletta Bio, Inc|Book Price of a Share Ventyx Biosciences, Inc (VTYX)|Book Value per Share THTX (Theratechnologies Inc.)|avalotx.com - Book Value per Share|Net Assets per Single Share Eledon Pharmaceuticals, Inc. (ELDN)|Agenus, Inc. (AGEN) - Accounting Value of a Share|Accounting Value per Share Climb Bio, Inc. CLYM|Accounting Value of a Share Zura Bio Ltd|aTyr Pharma, Inc. (ATYR) - Accounting Value per Share|Book Price of a Share Adagene Corp|ImageneBio Inc (IMA) - Book Value per Share|Accounting Value of a Share shattucklabs.com (STTK)|EQ: Book Value per Share|Connect Biopharma Holdings - Net Asset Value per Share|Net Assets per Single Share Immunic Inc (IMUX)|ATRA - Accounting Value of a Share|IFRX: Book Value per Share|XFOR (X4 Pharmaceuticals Inc.) - Book Value per Share|Net Assets per Single Share Adicet Bio Inc. ACET|Share Book Value Celularity Corp|INmune Bio, Inc. - Book Value per Share|Net Asset Value per Share barinthusbio.com BRNS|Accounting Value per Share KZR (Kezar Life Sciences, Inc.)|SABS - Book Value per Share|Accounting Value per Share Akari Therapeutics plc AKTX|ENLV - Book Price of a Share|q32bio.com - Book Value per Share|geovax.com (GOVX) - Net Assets per Share|Book Value per Share EDSA|Accounting Value per Share IBIO|CARM (Carisma Therapeutics) - Net Assets per Single Share|Net Assets per Share XTLB (XTL Bio)|BOLT - Net Assets per Single Share|HCW Biologics, Inc. - Equity per Share|Aptevo - Net Assets per Single Share|AIM ImmunoTech, Inc. (AIM) - Book Value per Share|ADTX - Accounting Value per Share|GRI (GRI Bio Corporation) - Book Price of a Share|XRTX - Net Assets per Single Share|Accounting Value of a Share HIND|REVB - Net Assets per Single Share|Share Book Value Indaptus Therapeutics Inc (INDP)|Book Value per Share Scinai|Accounting Value of a Share CalciMedica Inc CALI|Affimed Therapeutics - Book Value per Share|ALLK: Book Value per Share|Net Assets per Single Share hookipapharma.com HOOK|IGMS (IGM Biosciences) - Accounting Value of a Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share thirdharmonicbio.com THRD